Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Quesada Calvo, C. Crahay, R. Maree, D. de Seny, G. Paulissen, M. Gueders, L. Wehenkel, R. Louis, J. M. Foidart, A. Noel, M. Fillet, D. Cataldo (Liege, Belgium). Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models. Eur Respir J 2008; 32: Suppl. 52, 1731

Member's Comments

No comment yet.

Related content which might interest you: Mass spectrometry proteomic biomarkers identify acute COPD exacerbations Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Development of mass spectrometry approaches to quantifying lipid mediators in airway disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Metabolic profiling detects biomarkers of protein degradation in COPD patients Source: Eur Respir J 2012; 40: 345-355 Year: 2012 LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018 Detection of pregnancy in horses by breath analysis using differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011 Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Diagnostic accuracy of SELDI-TOF-MS (surface enhanced laser desabsorbtion ionization time of flight mass spectrometry) method in early diagnosis of lung cancer Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 A liquid chromatography MS/MS metabolomics study of COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Quantitative intact proteomics investigations of alveolar macrophages in sarcoidosis Source: Eur Respir J 2013; 41: 1331-1339 Year: 2013 Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Desmosine as a biomarker of elastin degradation in COPD: current status and future directions Source: Eur Respir J 2008; 32: 1146-1157 Year: 2008 Relationships between body mass index and clinical and functional characteristics in childhood asthma: A cross-sectional analysis Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma Year: 2011 Comparison of indirect measurements of multiple breath nitrogen washout with mass spectrometry. Source: International Congress 2019 – Exploring the lungs in various pathophysiological conditions Year: 2019 Identification of disease specific biomarkers by exhalomics using Secondary Electrospray Ionisation High-resolution Mass Spectrometry (SESI-HRMS) in children with cystic fibrosis Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Ion mobility spectrometry – a new method in the diagnostic approach to sarcoidosis? Preliminary data Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006 Breath analysis by ion mobility spectrometry in COPD and lung cancer patients Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 Ion mobility spectrometry in medical diagnostics: proof of inflammation markers in different parliamentary groups of the exhaled breath Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008